InsidersTradesSigma
Cinclus Pharma Holding AB (publ) Stock: price and directors' dealings · Finland · FIN-FSA
Track the Cinclus Pharma Holding AB (publ) stock price and the full insider trade history of the company, a listed equity based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Cinclus Pharma Holding AB (publ) has published 1 insider filings. Market capitalisation: €559.4m. The latest transaction was disclosed on 23 March 2026 (Purchase). Among the most active insiders: Jesper Wiklund. All data is openly available.
1
Insider Decl.
0
Thresholds
€10,009
1 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Cinclus Pharma Holding AB (publ) Strong Buy (bullish), based on 4 analysts. Average price target: SEK 46.25.
21Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 23 March 2026
Declarations1 total
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
6,000 shares@ €1.66820.0018% mcap100.0% of flowAktieFI:A003X228-1
Ideal exit: 15 Dec 2026 (T+270)
1 of 1 declaration